NEWTOWN, Pa., May 30, 2025 (GLOBE NEWSWIRE) — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Tempus AI, Inc. (NASDAQ: TEM), resulting from allegations of providing potentially misleading business information to the investing public.
If you have non-public information that could assist in the Tempus investigation, or if you are a Tempus investor who suffered a loss and would like to learn more, you can provide your information HERE.
You can also contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via e-mail at [email protected].
THE COMPANY:
Tempus is a health technology company developing AI-driven diagnostic tools for healthcare providers and researchers.
THE ALLEGED WRONGDOING:
On May 28, 2025, Spruce Point Capital Management published a report expressing concerns about Tempus AI’s financial reporting methods and the prior involvement of the company’s board members and executives with companies that had restated their financial results.
On this news, Tempus AI’s stock price plummeted by $12.67 per share, or 19.23%, to close at $53.20 per share on May 28, 2025.
ABOUT EDELSON LECHTZIN LLP: Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft, data security, and consumer fraud.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492 or 215-867-2399 ext. 1
Email: [email protected]
Email: [email protected]
Web: www.edelson-law.com
This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. Your ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow